Chronic Hepatitis D Virus Infection: Developing Drugs for Treatment Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 1, 2019
October 31, 2019
a162cb79-9621-497d-a34f-dd8e97dfa9b3
Related Documents
Stimulant Use Disorders: Developing Drugs for Treatment
Guidance DocumentOctober 5, 2023Center for Drug Evaluation and Research
Nonalcoholic Steatohepatitis with Compensated Cirrhosis: Developing Drugs for Treatment Guidance for Industry
Guidance DocumentJune 7, 2019Center for Drug Evaluation and Research
Respiratory Syncytial Virus Infection: Developing Antiviral Drugs for Prophylaxis and Treatment Guidance for Industry
Guidance DocumentOctober 11, 2017Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox